Organization · Private Equity
Hughes & Company
Hughes & Company is a private equity firm based in Chicago, Illinois, specializing in investments in lower middle market healthcare software and technology-enabled service companies. The firm focuses on driving revenue and EBITDA growth through active collaboration with its portfolio companies.
Overview
What Hughes & Company does
What Hughes & Company is
Hughes & Company is a private equity firm based in Chicago, Illinois, specializing in investments in lower middle market healthcare software and technology-enabled service companies. The firm focuses on driving revenue and EBITDA growth through active collaboration with its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Hughes & Company elsewhere
Open the official website or a supported primary organization account.
Capability profile
Hughes & Company as a funder
Investment thesis
Hughes & Company invests in lower middle market healthcare software and technology-enabled service companies, targeting growth and later-stage firms with proven business models. The firm emphasizes sustainable margin structures and market leadership potential in healthcare niches.
Focus narrative
Hughes & Company invests exclusively in lower middle market healthcare software and technology-enabled service companies. The firm does not invest in clinical services, pre-revenue companies, pharmaceuticals, biotechnology, or highly capital-intensive businesses. They target growth and later-stage companies with demonstrated business models and sustainable margin structures, focusing on market leadership potential in sustainable, growing healthcare niches. Investment sizes typically range from $5 million to over $50 million, with a variety of investment types including minority and majority control transactions, growth equity, leveraged buyouts, spin-outs, and strategic combinations.
Terms and economics
- Typical check
- $5,000,000–$50,000,000
Focus and fit
- Stages
- Growth Equity · Series B · Series C
- Sectors
- Healthcare
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Aldera and Aperture
Portfolio context
Hughes & Company's active investments include Azara Healthcare, which provides a population health management platform; Encoda, offering revenue cycle management technology; LifeLoop, delivering software for assisted living facilities; Valer, streamlining access to patient care; HDI, supporting data workflows in value-based care; and Curvo and BroadJump, creating a unified spend management platform. Notable exited investments include Aldera, sold to Evolent Health in 2016, and Aperture, sold to Stone Point Capital in 2021.
Common questions
What to know about Hughes & Company
Upseed classifies Hughes & Company under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.